Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297988260> ?p ?o ?g. }
- W4297988260 endingPage "6426" @default.
- W4297988260 startingPage "6426" @default.
- W4297988260 abstract "To address drug resistance to influenza virus neuraminidase inhibitors (NAIs), a series of novel boron-containing N-substituted oseltamivir derivatives were designed and synthesized to target the 150-cavity of neuraminidase (NA). In NA inhibitory assays, it was found that most of the new compounds exhibited moderate inhibitory potency against the wild-type NAs. Among them, compound 2c bearing 4-(3-boronic acid benzyloxy)benzyl group displayed weaker or slightly improved activities against group-1 NAs (H1N1, H5N1, H5N8 and H5N1-H274Y) compared to that of oseltamivir carboxylate (OSC). Encouragingly, 2c showed 4.6 times greater activity than OSC toward H5N1-H274Y NA. Moreover, 2c exerted equivalent or more potent antiviral activities than OSC against H1N1, H5N1 and H5N8. Additionally, 2c demonstrated low cytotoxicity in vitro and no acute toxicity at the dose of 1000 mg/kg in mice. Molecular docking of 2c was employed to provide a possible explanation for the improved anti-H274Y NA activity, which may be due to the formation of key additional hydrogen bonds with surrounding amino acid residues, such as Arg152, Gln136 and Val149. Taken together, 2c appeared to be a promising lead compound for further optimization." @default.
- W4297988260 created "2022-10-01" @default.
- W4297988260 creator A5003952522 @default.
- W4297988260 creator A5005686518 @default.
- W4297988260 creator A5008294104 @default.
- W4297988260 creator A5022140403 @default.
- W4297988260 creator A5031604617 @default.
- W4297988260 creator A5035724323 @default.
- W4297988260 creator A5048230989 @default.
- W4297988260 creator A5053639173 @default.
- W4297988260 creator A5057209439 @default.
- W4297988260 creator A5067355282 @default.
- W4297988260 creator A5067640187 @default.
- W4297988260 creator A5068590943 @default.
- W4297988260 creator A5069993144 @default.
- W4297988260 creator A5076251153 @default.
- W4297988260 creator A5079208868 @default.
- W4297988260 creator A5089524418 @default.
- W4297988260 date "2022-09-29" @default.
- W4297988260 modified "2023-10-17" @default.
- W4297988260 title "Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant" @default.
- W4297988260 cites W1463801548 @default.
- W4297988260 cites W1967283148 @default.
- W4297988260 cites W1974937210 @default.
- W4297988260 cites W1984114045 @default.
- W4297988260 cites W1988044361 @default.
- W4297988260 cites W1991159506 @default.
- W4297988260 cites W2019991523 @default.
- W4297988260 cites W2036499959 @default.
- W4297988260 cites W2037666515 @default.
- W4297988260 cites W2046745698 @default.
- W4297988260 cites W2062963124 @default.
- W4297988260 cites W2103191802 @default.
- W4297988260 cites W2131993780 @default.
- W4297988260 cites W2153207056 @default.
- W4297988260 cites W2156899051 @default.
- W4297988260 cites W2157356342 @default.
- W4297988260 cites W2170058011 @default.
- W4297988260 cites W2312463092 @default.
- W4297988260 cites W2320185978 @default.
- W4297988260 cites W2323929054 @default.
- W4297988260 cites W2338709508 @default.
- W4297988260 cites W2601225396 @default.
- W4297988260 cites W2621497207 @default.
- W4297988260 cites W2804446223 @default.
- W4297988260 cites W2811055392 @default.
- W4297988260 cites W2886881745 @default.
- W4297988260 cites W2890171249 @default.
- W4297988260 cites W2898524905 @default.
- W4297988260 cites W2922340592 @default.
- W4297988260 cites W2925128691 @default.
- W4297988260 cites W3006274289 @default.
- W4297988260 cites W3011152213 @default.
- W4297988260 cites W3018056400 @default.
- W4297988260 cites W3026327620 @default.
- W4297988260 cites W3081234543 @default.
- W4297988260 cites W3093187861 @default.
- W4297988260 cites W3112520974 @default.
- W4297988260 cites W3135063427 @default.
- W4297988260 cites W3151516662 @default.
- W4297988260 cites W3157812995 @default.
- W4297988260 cites W3159807548 @default.
- W4297988260 cites W3174769577 @default.
- W4297988260 cites W3211097194 @default.
- W4297988260 cites W4212907569 @default.
- W4297988260 cites W4213355150 @default.
- W4297988260 doi "https://doi.org/10.3390/molecules27196426" @default.
- W4297988260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36234966" @default.
- W4297988260 hasPublicationYear "2022" @default.
- W4297988260 type Work @default.
- W4297988260 citedByCount "4" @default.
- W4297988260 countsByYear W42979882602022 @default.
- W4297988260 countsByYear W42979882602023 @default.
- W4297988260 crossrefType "journal-article" @default.
- W4297988260 hasAuthorship W4297988260A5003952522 @default.
- W4297988260 hasAuthorship W4297988260A5005686518 @default.
- W4297988260 hasAuthorship W4297988260A5008294104 @default.
- W4297988260 hasAuthorship W4297988260A5022140403 @default.
- W4297988260 hasAuthorship W4297988260A5031604617 @default.
- W4297988260 hasAuthorship W4297988260A5035724323 @default.
- W4297988260 hasAuthorship W4297988260A5048230989 @default.
- W4297988260 hasAuthorship W4297988260A5053639173 @default.
- W4297988260 hasAuthorship W4297988260A5057209439 @default.
- W4297988260 hasAuthorship W4297988260A5067355282 @default.
- W4297988260 hasAuthorship W4297988260A5067640187 @default.
- W4297988260 hasAuthorship W4297988260A5068590943 @default.
- W4297988260 hasAuthorship W4297988260A5069993144 @default.
- W4297988260 hasAuthorship W4297988260A5076251153 @default.
- W4297988260 hasAuthorship W4297988260A5079208868 @default.
- W4297988260 hasAuthorship W4297988260A5089524418 @default.
- W4297988260 hasBestOaLocation W42979882601 @default.
- W4297988260 hasConcept C134164806 @default.
- W4297988260 hasConcept C142724271 @default.
- W4297988260 hasConcept C159047783 @default.
- W4297988260 hasConcept C181199279 @default.
- W4297988260 hasConcept C185592680 @default.
- W4297988260 hasConcept C2522874641 @default.
- W4297988260 hasConcept C2777538117 @default.